Medicine guide
Bonjesta 20 mg / 20 mg
As listed in the register: Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung
20 mg + 20 mg ·
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Doxylamini hydrogenosuccinas + Pyridoxini hydrochloridum
- Made by
- Exeltis Suisse SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- symptomatischen Behandlung von Übelkeit und Erbrechen während der Schwangerschaft bei Frauen, die nicht auf eine konservative Behandlung ansprechen
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Exeltis Suisse SA |
|---|---|
| Active substance | Doxylamini hydrogenosuccinas + Pyridoxini hydrochloridum |
| Used in | Breathing, airways, allergies and cough |
| Strength | 20 mg + 20 mg |
| Classification | R06AA59 · Breathing, airways, allergies and cough |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung |
| Packs | 10 Tablette(n) · 20 Tablette(n) · 30 Tablette(n) · 40 Tablette(n) · 50 Tablette(n) · 60 Tablette(n) |
| Zulassungsnummer | 68867 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.